VWF and atrial fibrillation: The same group had previously described an increased risk of bleeding complications, cardiovascular and all-cause mortality in patients with high levels of vWF during treatment with warfarin; nonetheless, only one third of the subjects in both studies had AF as the indication for OAC38.